Medications

Plozasiran reduces triglyceride levels by 74% at 24 weeks

In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing ...

Cardiology

Q&A: Healthy gums, healthy heart; what's the connection?

Healthy gums are imperative to a healthy mouth, but what about your cardiovascular health? In honor of Heart Month, Dr. Frank Nichols, professor of periodontics at the UConn School of Dental Medicine, unravels the underlying ...

Health

Lipoprotein(a): What to know about elevated levels

If you've listened to the radio or opened a webpage in the past year, you may have seen or heard ads promoting lipoprotein(a), or Lp(a), testing to help people identify risks for heart disease.

page 1 from 21